BioSpace News Archive

CyMedica completes early enrollment and launches rollover study of a clinical trial to evaluate the effectiveness of e-vive for reducing pain and improving function by increasing quadriceps strength in knee osteoarthritis patients. [16-June-2020] SCOTTSDALE, Ariz. , June 16, 2020 /PRNewswire/ -- CyMedica Orthopedics®, the leading combined muscle strengthening therapy

Erasca, a company whose mission is to erase cancer, today announced the expansion of its leadership team with the appointment of Bao Truong as vice president of regulatory affairs and David Luo as vice president of clinical research and operations. “We are delighted to continue attracti

Personalis, Inc. (Nasdaq:PSNL), a leader in advanced genomics for cancer, today announced that, effective on June 15, 2020, the Compensation Committee of its Board of Directors granted non-qualified stock options to purchase an aggregate of 67,900 shares of its common stock and restricted stock units (RSUs) covering an aggregate of 52,000 shares of its common stock to 12 new employees under Personalis’ 2020 Inducement

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infectious diseases, announces that it will host its 2020 Annual Shareholders Meeting virtually due to public health concerns related to the COVID-19.

Celerion is proud to announce, for the fifth consecutive year, recognition of its early stage research development services across five categories in the 2020 CRO Leadership Awards sponsored by Life Science Leader and Industry Standard Research. Both small and large pharma respondents highlighted Celerion as a top performer in categories including Capabilities, Compatibility, Expertise, and Quality . Importantly,

RenovaCare, Inc. announced the appointment of new Chief Financial Officer and Board Secretary, Mr. Robert W. Cook, who has more than 20 years of experience in senior financial leadership roles in healthcare, pharmaceuticals, and medical devices, and in the finance sector alone has completed more than $10 billion in transactions.

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal year 2020, ended March 31, 2020 , at 4:15pm Eastern time on Thursday , June 25, 2020. Management will host a conference call on Thursday

Blue Earth Diagnostics and PETNET Solutions Announce New Commercial Supply Agreement for Axumin® (Fluciclovine F 18) and Investigational rhPSMA-7.3 ( 18 F) Prostate Cancer Imaging Agent OXFORD, England & BURLINGTON, Mass.--( BUSINESS WIRE )-- Blue Earth Diagnostics, a Bracco company focused on molecular imaging diagnostics, and PETNET Solutions Inc., a Siemens Healthineers company specializing in the manufacturing and distribution of positron emission to

To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for 30 days following the live presentation.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has hired Vince DiMella as its U.S. Director of Sales and Ma